US 11634404
Selective D3 dopamine receptor agonists and methods of their use
granted A61PA61P25/14A61P25/16
Quick answer
US patent 11634404 (Selective D3 dopamine receptor agonists and methods of their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P25/14, A61P25/16, A61P25/28